Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

NCT02400346 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02400346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02400346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Flexible-dose, Long-term Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2016
Enrollment
132 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

major depression disorder